Walder Wyss has advised co-led investors Swisscanto and imec.xpand in connection with Nagi Bioscience’s Series A Financing round in the amount of CHF 12.4 million. The Swiss life sciences startup has secured an oversubscribed
Tags :Sebastien Aubert
H55 has successfully completed the first part of its Series C financing round securing CHF 45 million in financing. The Valais company has secured the investment of equity and non-dilutive financing in the first phase of
The Andera Acto team, in charge of mezzanine sponsorless strategy at Andera Partners, is assisting the Auris Gestion Group with its capital restructuring and development strate. Following a process organised by PAX Corporate Finance, the